论文信息 - An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL). - 字舞流文

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL).

J. Gribben | A. Pettitt | W. Gregory | G. Follows | D. Oscier | C. Dearden | A. Nathwani | Dena R. Cohen | D. Milligan | A. Rawstron | P. Hillmen | C. Pocock | Hazem A. Sayala | P. Moreton | D. B. Kennedy | C. Hayward